JavaScript is disabled for your browser. Some features of this site may not work without it.
Use of eCommons for rapid dissemination of COVID-19 research
In order to maximize the discoverability of COVID-19 research, and to conform with repository best practices and the requirements of publishers and research funders, we provide special guidance for COVID-19 submissions.
2018 CVM News: Advocates and scientists connect during Fibrolamellar Cancer Foundation visit to CVM
Abstract
This news item is about: The Fibrolamellar Cancer Foundation (FCF) recently held a research event at the College of Veterinary Medicine hosted by Praveen Sethupathy, Ph.D. '03, associate professor of biomedical sciences, who presented to fellow researchers, foundation board members, and a patient and his family on his current research toward finding therapeutic targets to fight fibrolamellar cancer. The Sethupathy lab specializes in discerning the function of non-coding RNAs, and through ongoing collaboration with other researchers, has discovered promising targets in the fight against this disease. “Praveen has done an admirable job of sharing information with other institutions,” says John Hopper, president of the FCF.
Date Issued
2018-07-23Publisher
Cornell University, College of Veterinary Medicine
Subject
Cornell University. College of Veterinary Medicine -- Periodicals.; Weiss, Robert; Sethupathy, Praveen
Type
article